• OPEN AN ACCOUNT
Indian Indices
Nifty
26,186.45 152.70
(0.59%)
Sensex
85,712.37 447.05
( 0.52%)
Bank Nifty
59,777.20 488.50
( 0.82%)
Nifty IT
38,703.65 343.40
( 0.90%)
Global Indices
Nasdaq
47,981.01 109.07
(0.23%)
Dow Jones
6,892.33 14.21
(0.21%)
Hang Seng
50,440.45 -587.97
(-1.15%)
Nikkei 225
9,667.01 -43.86
(-0.45%)
Forex
USD-INR
89.99 -0.14
(-0.16%)
EUR-INR
104.92 -0.11
(-0.11%)
GBP-INR
120.05 0.29
(0.24%)
JPY-INR
0.58 0.00
(0.11%)

EQUITY - MARKET SCREENER

Prism Medico & Pharmacy Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
512217
INE730E01016
24.8915762
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
17.49
10.6
EPS(TTM)
Face Value()
Div & Yield %
1
10
0
 

Emmsons International Ltd - Board Meeting Outcome for Outcome Of Board Meeting And Intimation Under Regulation 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Quarter Ended On 30Th June 2025 .
Aug 14,2025
This is to inform you that the Board of Directors of the Company at its meeting held today i.e. Thursday 14th August 2025 have inter-alia considered and approved the followings: 1. The Un-audited Standalone Financial Results of the Company for the first quarter ended on 30th June 2025 (Results including auditors Limited Review Report attached as Annexure-I). 2. The Un-audited Consolidated Financial Results of the Company for the first quarter ended on 30th June 2025 (Results including auditors Limited Review Report attached as Annexure-II).